Why the study?
Does frailty predict short-term adverse outcomes in elderly patients with non-ST-segment elevation myocardial infarction?
Population
307 patients aged ≥ 75 years with diagnosed non-ST-segment elevation myocardial infarction
Comparison
Frailty vs Non-frail patients
Design
Cohort
Follow-up
1 month
Authors
Loading...
May aid short-term risk stratification in elderly NSTEMI; hypothesis-generating pending prospective validation.
Does frailty predict short-term adverse outcomes in elderly patients with non-ST-segment elevation myocardial infarction?
Frailty is a strong, independent predictor of short-term mortality and adverse events in elderly patients presenting with NSTEMI.
Ekerstad et al. (2011) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: